Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus

NCT00004662 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

NIH

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: dehydroepiandrosterone

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]